Cuban health ministry ( MINSAP by its Spanish acronym)) reported today that 9 970 913 people (90 %) have completed the anti-COVID-19 vaccination program, with the immunogens developed in the country, Soberana 02, Soberana Plus and Abdala.»
The director of Bio-Medical Research at Cuba’s Genetic Engineering and Biotech Center, Gerardo Guillen, said the clinical tests phase I and II for homegrown intra-nasal COVID-19 vaccine MAMBISA were successful.»
Cuba's Ministry of Public Health reports that the Caribbean country currently maintains a downward trend of COVID-19 cases. But, at the same time, it urged people not to be overly confident and comply with the established health measures»
According to statistics from April 8, the Minsap informed that a total of 35 519 808 doses of the homegrown Soberana 02, Soberana Plus and Abdala vaccines have been administered so far.»
The creators of the Cuban anti-COVID-19 vaccines Soberana 01, Soberana 02, Abdala, and Mambisa received the Gold Medal for Inventors conferred by the World Intellectual Property Organization (WIPO).»
A total of 34,926,914 doses of vaccines against the SARS-CoV-2 coronavirus, which causes Covid-19, have been administered in Cuba, the Ministry of Public Health (MINSAP) reported on Friday»
WHO has called for a moratorium on third vaccine doses amid global vaccine inequity»
Escambray ENGLISH EDITION